- (HealthDay News) — Here are the latest clinical trials, courtesy
of Thomson CenterWatch:

Adenocarcinoma

This study will evaluate an investigational drug's
effectiveness, when used in combination with other drugs, in slowing the
progression of breast cancer. Participants must be at least 18, diagnosed
with HER2-positive metastatic breast cancer, and be eligible for
chemotherapy.

The research site is in Jonesboro, Ark.

More information

Please see http://www.centerwatch.com/patient/studies/cat546.html.<
/p>

—–

Migraine and Cluster Headaches

This study will evaluate an investigational medication
to treat migraines. Participants must be at least 18, have a history of
migraines for at least one year, and have had one to eight migraine
attacks per month for the past two months. Participants will be
compensated for time and travel.

The research site is in Nashville,
Tenn.

More information

Please see http://www.centerwatch.com/patient/studies/cat100.html.<
/p>

—–

Pancreatic Cancer

This study will assess the safety and effectiveness of
TNFerade in combination with 5-FU and radiation therapy as first-line
treatments for unresectable locally advanced pancreatic cancer. Patients
must be 18 or older, and additional eligibility criteria apply.

The
research site is in Los Angeles, Calif.

More information

Please seehttp://www.centerwatch.com/patient/studies/cat35.html. p>

—–

Copyright 2008 Thomson CenterWatch. All rights reserved.